It is important to note that if ED develops or worsens during GLP-1 therapy, this is more likely related to the underlying conditions being treated (diabetes, obesity, cardiovascular disease) or other concurrent factors rather than the medication itself
Guan B, Chen Y, Yang J, Yang W, Wang C
Nausea is typically transient and can be minimised through gradual dose titration
Regulatory Information Disclaimer: Statements in this article regarding FDA actions, the 503B Bulks List, drug shortage status, and the federal regulatory framework for compounded GLP-1 medications reflect FDA published guidance current as of May 2026
However, if you'd rather avoid the stimulant, opt for caffeine-free supplements instead
Beauty Bank Membership: Elevate Your Aesthetic Journey at Admire At Admire Aesthetics, our exclusive Beauty Bank Membership is designed to enhance your wellness and radiance